share_log

Needham Reiterates Buy on Harmony Biosciences, Maintains $50 Price Target

Needham Reiterates Buy on Harmony Biosciences, Maintains $50 Price Target

尼德姆重申买入Harmony Biosciences,维持50美元的目标股价
Moomoo 24/7 ·  04/09 06:24

Needham analyst Ami Fadia reiterates Harmony Biosciences (NASDAQ:HRMY) with a Buy and maintains $50 price target.

Needham分析师阿米·法迪亚重申Harmony Biosciences(纳斯达克股票代码:HRMY)的买入并维持50美元的目标股价。

声明:本内容仅用作提供资讯及教育之目的,不构成对任何特定投资或投资策略的推荐或认可。 更多信息
    抢沙发